Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1985-06-20
1987-07-14
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514291, 514292, 514250, A61K 3150, A61K 31495, A61K 3144
Patent
active
046802975
ABSTRACT:
Substituted quinoline, [1,5]- and [1,8]-naphthyridine and pyrido [2,3-b]pyrazine derivatives are useful positive inotropic agents.
REFERENCES:
patent: 4113731 (1978-09-01), Winters et al.
patent: 4232017 (1980-11-01), Winters et al.
patent: 4452800 (1984-06-01), Sherlock
Bulletin de la Societe Chimique de France, No. 1, 1968, pp. 364-369, Paris, FR; C. Fournier et al.
Chemical Abstracts, vol. 88, 1978, pp. 570-571, No. 105298y.
Journal of the Chemical Society, Perkin Transaction 1, Sep. 1983, pp. 2077-2087, London, GB; D. G. Hawkins et al.
Chemical Abstracts, vol. 101, No. 5, 30th Jul. 1984, p. 504, No. 38382t, E. M. Peresleni et al.
Japanese published patent 5-8-144-391 (abstract thereof).
Blythin David J.
Watkins Robert W.
Billups Richard C.
Lipovsky Joseph A.
Miller Stephen I.
Nelson James R.
Schenkman Leonard
LandOfFree
Tricyclic positive inotropic agents does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tricyclic positive inotropic agents, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tricyclic positive inotropic agents will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1427713